Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.3 (
RNase III
)
1,015
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The synthesis rates of
ribonuclease III
(
RNase III
) and Era proteins are relatively low, and expression of the era gene is translationally coupled with expression of the rnc gene. Expression of both genes is negatively controlled by
RNase III
itself. We have constructed plasmids that overproduce
RNase III
and/or Era proteins under the control of the lambda PL promoter. A plasmid with the rnc gene under PL control expresses
RNase III
at levels greater than 40% of total cellular protein. Another plasmid with the era gene under PL control and a modified translation-initiation signal produces up to 80% of total cell protein as Era. Each protein has been purified using simple and rapid procedures. Purified
RNase III
protein specifically processes mRNA transcripts containing known
RNase III
sites. The purified Era protein binds
GDP
and GTP and has GTPase activity. Kinetic analysis shows that one molecule of GTP or
GDP
is bound/Era peptide with a Kd of 5.5 microM for GTP binding and 1.0 microM for
GDP
binding. The Km of the Era GTPase is 9.0 microM, and the maximum catalyzed rate of GTP hydrolyzed/min/mol of Era protein at 37 degrees C is 9.8 mmol.
...
PMID:Expression and characterization of RNase III and Era proteins. Products of the rnc operon of Escherichia coli. 210 34